ERNA vs NVR · P/E 0.0, rev $582.0K vs P/E 15, rev $10.52B
Eterna Therapeutics Inc (ERNA) versus NVR Inc (NVR) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
NVR Inc (NVR) is a residential construction company listed on NYSE.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported NVR revenue for 2024-12-31 was $10.52B. Net income was $1.68B. Revenue was up 10.6% from 2023-12-31 to 2024-12-31. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
Not investment advice. Open the ERNA and NVR stock pages for the full models.
Not investment advice.